Terms: = Germ cell tumor AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1
383 results:
1. The involvement of RIPK4 in TNF-α-stimulated IL-6 and IL-8 production by melanoma cells.
Madej E; Lisek A; Brożyna AA; Cierniak A; Wronski N; Deptula M; Wardowska A; Wolnicka-Glubisz A
J Cancer Res Clin Oncol; 2024 Apr; 150(4):209. PubMed ID: 38656555
[TBL] [Abstract] [Full Text] [Related]
2. TGF-β-activated circRYK drives glioblastoma progression by increasing VLDLR mRNA expression and stability in a ceRNA- and RBP-dependent manner.
Wang Y; Wang B; Cao W; Xu X
J Exp Clin Cancer Res; 2024 Mar; 43(1):73. PubMed ID: 38454465
[TBL] [Abstract] [Full Text] [Related]
3. Multiregion WES of metastatic pancreatic neuroendocrine tumors revealed heterogeneity in genomic alterations, immune microenvironment and evolutionary patterns.
Jiang Y; Dong YH; Zhao SW; Liu DY; Zhang JY; Xu XY; Chen H; Chen H; Jin JB
Cell Commun Signal; 2024 Mar; 22(1):164. PubMed ID: 38448900
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic value of CT-based radiomics in grade 1-2 pancreatic neuroendocrine tumors.
Heo S; Park HJ; Kim HJ; Kim JH; Park SY; Kim KW; Kim SY; Choi SH; Byun JH; Kim SC; Hwang HS; Hong SM
Cancer Imaging; 2024 Feb; 24(1):28. PubMed ID: 38395973
[TBL] [Abstract] [Full Text] [Related]
5. Immunohistochemical double nuclear staining for cell-specific automated quantification of the proliferation index - A promising diagnostic aid for melanocytic lesions.
Brogård MB; Nielsen PS; Christensen KB; Georgsen JB; Wandler A; Lade-Keller J; Steiniche T
Pathol Res Pract; 2024 Mar; 255():155177. PubMed ID: 38330618
[TBL] [Abstract] [Full Text] [Related]
6. Intratumoral administration of the immunologic adjuvant AS01
Tijtgat J; Geeraerts X; Boisson A; Stevens L; Vounckx M; Dirven I; Schwarze JK; Raeymaeckers S; Forsyth R; Van Riet I; Tuyaerts S; Willard-Gallo K; Neyns B
J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38212127
[TBL] [Abstract] [Full Text] [Related]
7. Stereotactic radiosurgery of brain metastases: a retrospective study.
Gruber I; Weidner K; Treutwein M; Koelbl O
Radiat Oncol; 2023 Dec; 18(1):202. PubMed ID: 38115009
[TBL] [Abstract] [Full Text] [Related]
8. Bioinformatics analyses and experimental validation of the role of phagocytosis in low-grade glioma.
Fei M; Lu C; Feng B; Sun J; Wang J; Sun F; Dong B
Environ Toxicol; 2024 Apr; 39(4):2182-2196. PubMed ID: 38112449
[TBL] [Abstract] [Full Text] [Related]
9. Clinical Predictors of Survival in Patients With BRAFV600-Mutated Metastatic Melanoma Treated With Combined BRAF and MEK Inhibitors After Immune Checkpoint Inhibitors.
Kahn AM; Perry CJ; Etts K; Kluger H; Sznol M
Oncologist; 2024 Apr; 29(4):e507-e513. PubMed ID: 37971411
[TBL] [Abstract] [Full Text] [Related]
10. Effectiveness of Immune Checkpoint Inhibitor with Anti-PD-1 Monotherapy or in Combination with Ipilimumab in Younger versus Older Adults with Advanced Melanoma.
Woo TE; Stukalin I; Ding PQ; Goutam S; Sander M; Ewanchuk B; Cheung WY; Heng DYC; Cheng T
Curr Oncol; 2023 Sep; 30(10):8936-8947. PubMed ID: 37887546
[No Abstract] [Full Text] [Related]
11. Targeting TNFAIP2 induces immunogenic cell death and sensitizes glioblastoma multiforme to anti-PD-1 therapy.
Hou C; Shi S; Gao M; Ji J; Ma C; Wang T; Chen T; Liu Y; Zhong J; Zheng Y; Ye J; Ke Y
J Neurooncol; 2023 Oct; 165(1):79-90. PubMed ID: 37819535
[TBL] [Abstract] [Full Text] [Related]
12. Comparison of three-weekly and six-weekly pembrolizumab United Kingdom prescribing practice for advanced and resected melanoma.
Mehta I; Dayimu A; Kumar S; Boobier C; Oladipo O; Burke D; Olson-Brown A; Yesildag P; Nobes J; Brown S; Booth C; Wheater M; Muller D; Fountain V; Ford L; Board R; McGurk L; Twelves S; Demiris N; Corrie P
Eur J Cancer; 2023 Nov; 194():113344. PubMed ID: 37804771
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic value of indoleamine 2, 3-dioxygenase-1 expression in glial tumors.
Kaya M; Aksoy A; Artas G; Kaplan M
Ideggyogy Sz; 2023 Sep; 76(9-10):339-347. PubMed ID: 37782060
[TBL] [Abstract] [Full Text] [Related]
14. Non-invasive differential diagnosis of teratomas from other intracranial germ cell tumours using MRI-based fractal and radiomic analyses.
Liu S; Wang X; Liu X; Li S; Liao H; Qiu X
Eur Radiol; 2024 Mar; 34(3):1434-1443. PubMed ID: 37672052
[TBL] [Abstract] [Full Text] [Related]
15. METTL3 Promotes the Growth and Invasion of Melanoma cells by Regulating the lncRNA SNHG3/miR-330-5p Axis.
Chu S; Li Y; Wu B; Rong G; Hou Q; Zhou Q; Du D; Li Y
Cell Transplant; 2023; 32():9636897231188300. PubMed ID: 37606168
[TBL] [Abstract] [Full Text] [Related]
16. Observational study of surgical resection in small non-functional pancreatic neuroendocrine tumors: AS SEER-based study.
Lin J; Huang H
Sci Rep; 2023 Aug; 13(1):12824. PubMed ID: 37550460
[TBL] [Abstract] [Full Text] [Related]
17. Human Papillomavirus and Retinoblastoma: Evidence From a Systematic Review and Meta-analysis of Cross-Sectional Studies.
Feng H; Deng Y
Int J Public Health; 2023; 68():1605284. PubMed ID: 37497122
[No Abstract] [Full Text] [Related]
18. Skin Cancer and Hydrochlorothiazide: Novel Population-Based Analyses Considering Personal Risk Factors Including Race/Ethnicity.
Birck MG; Moura CS; Machado MAA; Liu JL; Abrahamowicz M; Pilote L; Bernatsky S
Hypertension; 2023 Oct; 80(10):2218-2225. PubMed ID: 37489540
[TBL] [Abstract] [Full Text] [Related]
19. Association Between Pseudoprogression of Vestibular Schwannoma After Radiosurgery and Radiological Features of Solid and Cystic Components.
Huang CY; Peng SJ; Yang HC; Wu HM; Chen CJ; Wang MC; Hu YS; Lin CJ; Shiau CY; Guo WY; Chung WY; Pan DH; Lee CC
Neurosurgery; 2023 Dec; 93(6):1383-1392. PubMed ID: 37432016
[TBL] [Abstract] [Full Text] [Related]
20. Targeting Upregulated ciap2 in SOX10-Deficient Drug Tolerant Melanoma.
Glasheen MQ; Caksa S; Young AG; Wilski NA; Ott CA; Chervoneva I; Flaherty KT; Herlyn M; Xu X; Aplin AE; Capparelli C
Mol Cancer Ther; 2023 Sep; 22(9):1087-1099. PubMed ID: 37343247
[TBL] [Abstract] [Full Text] [Related]
[Next]
